Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific NYSE:TMO |
184,37 B | 5,37% | 3/6 | 6,11% | 16,21% | 34,04% | DOWN |
|
Natera NasdaqGS:NTRA |
27,36 B | 30,44% | 5/6 | 18,61% | -114,68% | 34,69% | UP |
|
Illumina NasdaqGS:ILMN |
18,49 B | -2,54% | 3/6 | 17,60% | 67,11% | 15,77% | UP |
|
Guardant Health NasdaqGS:GH |
10,31 B | 21,36% | 2/6 | 29,56% | -42,85% | 65,39% | DOWN |
|
Qiagen N.V. NYSE:QGEN |
8,46 B | 1,98% | 5/6 | 5,53% | 21,27% | 33,28% | DOWN |
|
Tempus AI NasdaqGS:TEM |
7,70 B | 83,41% | 0/0 | 25,24% | -1,23% | 68,84% | DOWN |
|
Sysmex TSE:6869 |
862,62 B | 10,11% | 5/5 | -9,42% | 56,56% | 18,88% | DOWN |
|
Veracyte NasdaqGM:VCYT |
2,47 B | 42,38% | 5/6 | 9,00% | -0,27% | 54,39% | DOWN |
|
Adaptive Biotechnologies NasdaqGS:ADPT |
1,97 B | 20,58% | 5/6 | 1,73% | -27,54% | 64,19% | DOWN |
|
Mesoblast ASX:MSB |
2,74 B | -23,16% | 4/6 | 580,42% | 55,49% | 81,13% | DOWN |
|
Axogen NasdaqCM:AXGN |
1,66 B | 44,94% | 4/6 | 41,04% | -193,56% | 25,16% | UP |
|
NeoGenomics NasdaqCM:NEO |
1,00 B | 5,19% | 3/6 | 13,90% | 52,27% | 95,06% | DOWN |
|
Personalis NasdaqGM:PSNL |
0,63 B | -18,04% | 1/5 | 12,67% | -191,19% | 82,72% | DOWN |
|
MiMedx Group NasdaqCM:MDXG |
0,58 B | 50,84% | 4/6 | -33,69% | 22,85% | 158,40% | DOWN |
|
Orthofix Medical NasdaqGS:OFIX |
0,50 B | 4,54% | 1/6 | -40,02% | 49,24% | 41,36% | DOWN |
|
Lineage Cell Therapeutics NYSEAM:LCTX |
0,37 B | 41,30% | 4/6 | 71,08% | -4,77% | 136,49% | UP |
|
Compugen NasdaqCM:CGEN |
0,24 B | 100,69% | 3/6 | -84,41% | 59,06% | 55,04% | UP |
|
Embracing Future Holdings Catalist:8YY |
0,10 B | 0,00% | 1/2 | 0,00% | 0,00% | -100,00% | UP |
|
Xtant Medical Holdings NYSEAM:XTNT |
0,07 B | 0,00% | 3/6 | -62,50% | 15,06% | 129,17% | DOWN |
|
Atossa Therapeutics NasdaqCM:ATOS |
0,04 B | 0,00% | 2/4 | 0,00% | 0,00% | 355,47% | DOWN |
